267 related articles for article (PubMed ID: 30367282)
1. The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics.
Parashar A; Hundley WG
Curr Cardiol Rep; 2018 Oct; 20(12):142. PubMed ID: 30367282
[TBL] [Abstract][Full Text] [Related]
2. Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance.
Vasu S; Hundley WG
J Cardiovasc Magn Reson; 2013 Jul; 15(1):66. PubMed ID: 23902649
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S45-54. PubMed ID: 27183525
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e45-e54. PubMed ID: 27755242
[TBL] [Abstract][Full Text] [Related]
5. Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient.
Plana JC; Thavendiranathan P; Bucciarelli-Ducci C; Lancellotti P
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1173-1186. PubMed ID: 30092972
[TBL] [Abstract][Full Text] [Related]
6. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
[TBL] [Abstract][Full Text] [Related]
7. Role of cardiovascular magnetic resonance imaging in cardio-oncology.
Saunderson CED; Plein S; Manisty CH
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):383-396. PubMed ID: 33404058
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D
Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419
[TBL] [Abstract][Full Text] [Related]
9. Multimodality Imaging for Cardiotoxicity: State of the Art and Future Perspectives.
Artico J; Abiodun A; Shiwani H; Kurdi H; Chen D; Tyebally S; Moon JC; Westwood M; Manisty CH
J Cardiovasc Pharmacol; 2022 Oct; 80(4):547-561. PubMed ID: 35522143
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.
Puckett LL; Saba SG; Henry S; Rosen S; Rooney E; Filosa SL; Gilbo P; Pappas K; Laxer A; Eacobacci K; Kapyur AN; Robeny J; Musial S; Chaudhry A; Chaudhry R; Lesser ML; Riegel A; Ramoutarpersaud S; Rahmani N; Shah A; Papas V; Dawodu T; Charlton J; Knisely JPS; Lee L
Cancer Med; 2021 Aug; 10(15):5051-5061. PubMed ID: 34245128
[TBL] [Abstract][Full Text] [Related]
11. Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship.
de Wall C; Bauersachs J; Berliner D
Clin Exp Metastasis; 2021 Aug; 38(4):361-371. PubMed ID: 34117981
[TBL] [Abstract][Full Text] [Related]
12. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
Garg V; Vorobiof G
Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
[TBL] [Abstract][Full Text] [Related]
13. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Magnetic Resonance Imaging: Identifying the Effects of Cancer Therapy.
Houbois CP; Thavendiranathan P; Wintersperger BJ
J Thorac Imaging; 2020 Jan; 35(1):12-25. PubMed ID: 31211728
[TBL] [Abstract][Full Text] [Related]
15. Cancer as a Risk Factor for Cardiovascular Disease.
Giza DE; Iliescu G; Hassan S; Marmagkiolis K; Iliescu C
Curr Oncol Rep; 2017 Jun; 19(6):39. PubMed ID: 28421481
[TBL] [Abstract][Full Text] [Related]
16. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
Lenneman CG; Sawyer DB
Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment.
Yegya-Raman N; Berlin E; Feigenberg SJ; Ky B; Sun L
Curr Oncol Rep; 2023 May; 25(5):433-444. PubMed ID: 36811807
[TBL] [Abstract][Full Text] [Related]
18. Advanced imaging modalities to detect cardiotoxicity.
Awadalla M; Hassan MZO; Alvi RM; Neilan TG
Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
[TBL] [Abstract][Full Text] [Related]
19. The Role of Multimodality Cardiac Imaging in Patients Undergoing Cancer Treatment.
Wengrofsky P; Feldman S
Curr Cardiol Rep; 2023 Jan; 25(1):1-8. PubMed ID: 36527535
[TBL] [Abstract][Full Text] [Related]
20. Cardiac imaging in cardiotoxicity: a focus on clinical practice.
Makavos G; Ikonomidis I; Palios J; Rigopoulos A; Katogiannis K; Parissis J; Paraskevaidis I; Noutsias M
Heart Fail Rev; 2021 Sep; 26(5):1175-1187. PubMed ID: 32306221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
